• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Tuberculosis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

The global tuberculosis diagnostics market grew at a CAGR of around 5% during 2014-2019. Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs. In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient’s sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.

The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB. Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques. Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor. Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further. Looking forward, IMARC Group expects the global tuberculosis diagnostics market to exhibit moderate growth during 2020-2025.


Breakup by Disease Stage:

  • Latent TB
  • Active TB
     

Breakup by Test Type:

  • Radiographic Test
  • Laboratory Test
    • Smear Microscopy
    • Culture-based Test
  • Nucleic Acid Testing
  • Cytokine Detection Test
  • Drug Resistance Test
  • Others
     

Breakup by End-User:

  • Hospitals and Clinics
  • Diagnostics and Research Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

 

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMérieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global tuberculosis diagnostics market?
  • What is the breakup of the market based on the disease stage?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global tuberculosis diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Tuberculosis Diagnostics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Disease Stage
    6.1    Latent TB
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Active TB
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Test Type
    7.1    Radiographic Test
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Laboratory Test
        7.2.1 Market Trends
        7.2.2 Major Types
           7.2.2.1 Smear Microscopy
           7.2.2.2 Culture-based Test
        7.2.3 Market Forecast
    7.3    Nucleic Acid Testing
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Cytokine Detection Test
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Drug Resistance Test
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by End-User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Diagnostics and Research Laboratories
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Indicators
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Alere Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio 
        14.3.3    Becton Dickinson and Company
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    BioMérieux
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Cepheid Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 SWOT Analysis
        14.3.6    Epistem Ltd.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
        14.3.7    Roche Holding AG
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio 
           14.3.7.3 Financials
        14.3.8    Hain Lifescience GmbH
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 
           14.3.8.3 Financials
        14.3.9    Hologic Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    QIAGEN GmbH
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials
        14.3.11    Siemens
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio 
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Thermo Fisher Scientific Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio 
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis


List of Figures

Figure 1: Global: Tuberculosis Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Tuberculosis Diagnostics Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Tuberculosis Diagnostics Market: Breakup by Disease Stage (in %), 2019
Figure 4: Global: Tuberculosis Diagnostics Market: Breakup by Test Type (in %), 2019
Figure 5: Global: Tuberculosis Diagnostics Market: Breakup by End-User (in %), 2019
Figure 6: Global: Tuberculosis Diagnostics Market: Breakup by Region (in %), 2019
Figure 7: Global: Tuberculosis Diagnostics Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 8: Global: Tuberculosis Diagnostics (Latent TB) Market: Sales Value (in Million US$), 2014 & 2019
Figure 9: Global: Tuberculosis Diagnostics (Latent TB) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 10: Global: Tuberculosis Diagnostics (Active TB) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Tuberculosis Diagnostics (Active TB) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Tuberculosis Diagnostics (Radiographic Test) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Tuberculosis Diagnostics (Radiographic Test) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Tuberculosis Diagnostics (Laboratory Test) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Tuberculosis Diagnostics (Laboratory Test) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market: Sales Value (in Million US$), 2014 & 2019
Figure 19: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 22: Global: Tuberculosis Diagnostics (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 23: Global: Tuberculosis Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 24: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 25: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 26: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
Figure 27: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 28: Global: Tuberculosis Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
Figure 29: Global: Tuberculosis Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 30: North America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 31: North America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 32: United States: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 33: United States: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 34: Canada: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 35: Canada: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 36: Asia Pacific: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 37: Asia Pacific: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 38: China: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 39: China: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 40: Japan: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 41: Japan: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 42: India: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 43: India: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 44: South Korea: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 45: South Korea: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 46: Australia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 47: Australia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 48: Indonesia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 49: Indonesia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 50: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 51: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 52: Europe: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 53: Europe: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 54: Germany: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 55: Germany: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 56: France: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 57: France: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 58: United Kingdom: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 59: United Kingdom: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 60: Italy: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 61: Italy: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 62: Spain: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 63: Spain: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 64: Russia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 65: Russia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 66: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 67: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 68: Latin America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 69: Latin America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 70: Brazil: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 71: Brazil: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 72: Mexico: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 73: Mexico: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 74: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 75: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 76: Middle East and Africa: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
Figure 77: Middle East and Africa: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 78: Global: Tuberculosis Diagnostics Industry: SWOT Analysis
Figure 79: Global: Tuberculosis Diagnostics Industry: Value Chain Analysis
Figure 80: Global: Tuberculosis Diagnostics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Tuberculosis Diagnostics Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Disease Stage (in Million US$), 2020-2025
Table 3: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2020-2025
Table 4: Global: Tuberculosis Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2020-2025
Table 5: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 6: Global: Tuberculosis Diagnostics Market: Competitive Structure
Table 7: Global: Tuberculosis Diagnostics Market: Key Players        

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links